Repligen Corporation (RGEN): Price and Financial Metrics
RGEN Price/Volume Stats
| Current price | $116.25 | 52-week high | $182.52 |
| Prev. close | $124.04 | 52-week low | $102.96 |
| Day low | $115.19 | Volume | 1,033,277 |
| Day high | $124.35 | Avg. volume | 744,795 |
| 50-day MA | $124.96 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 6.53B |
RGEN Stock Price Chart Interactive Chart >
Repligen Corporation (RGEN) Company Bio
Repligen Corporation develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. The company was founded in 1981 and is based in Waltham, Massachusetts.
RGEN Price Returns
| 1-mo | -1.10% |
| 3-mo | N/A |
| 6-mo | -27.57% |
| 1-year | -8.92% |
| 3-year | -30.83% |
| 5-year | -13.45% |
| YTD | -19.24% |
| 2024 | -19.94% |
| 2023 | 6.20% |
| 2022 | -36.07% |
| 2021 | 38.20% |
| 2020 | 107.17% |
Continue Researching RGEN
Want to see what other sources are saying about Repligen Corp's financials and stock price? Try the links below:Repligen Corp (RGEN) Stock Price | Nasdaq
Repligen Corp (RGEN) Stock Quote, History and News - Yahoo Finance
Repligen Corp (RGEN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...